Found "Public health policy": 1,149 results
Sort by
Relevance

Development and evaluation of mobile-based health behaviour change intervention to support tobacco smoking cessation in Thailand

Tobacco smoking is widely recognised as one of the leading threats to population health. Around 21% of the Thai population currently smoke. It was estimated that 51,000 deaths and 755,000 disability-adjusted life years (DALYs) lost are due to tobacco use. Results from published meta-analyses suggest

Navigating the Landscape of Digital Health: United Kingdom

Digital health technologies (DHTs) represent various products used in the healthcare system, including software, applications (apps) and online platforms benefiting individuals and the wider health and social care system. It is a field characterised by complexity and dynamism. The English digital

Concept note: Rapid assessment of road traffic injuries related policies and their economic impact in Sri Lanka

Road traffic accidents (RTAs) represent an increasing human and socio-economic problem worldwide and have been identified as one of the target areas under the Sustainable Development Goals (SDGs) to “halve the number of global deaths and injuries from road traffic accidents” (SDG 3.6). In Sri Lanka,

High Doses of Hormones Faulted in Fertility Care

Two days after Debra Demidon underwent in vitro fertilization, she gained more than 30 pounds in fluid and suddenly was struggling to breathe.Doctors diagnosed severe ovarian hyperstimulation syndrome (OHSS), a complication seen in some women who undergo fertility treatment. It landed Ms. Demidon in

Vaccination program in a resource-limited setting: A case study in the Philippines

Objective: Implementing national-level vaccination programs involves long-term investment, which can be a significant financial burden, particularly in resource-limited settings. Although many studies have assessed the economic impacts of providing vaccinations, evidence on the positive and negative

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

Summary The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that protect against severe disease and preferably drive herd immunity. Regulators in numerous countries have authorised or approved COVID-19 vaccines for human use, with more expected to be licensed in 20

The HITAP International Unit (HIU) heads to Indonesia

The recent Indonesia visit is an illustration of iDSI’s ongoing commitment to building capacity in developing countries. HITAP visits help national bodies learn how to conduct Health Technology Assessments, strengthening decision-making processes and enabling gains in the quantity and quality of hea

iDSI celebrates Universal Health Coverage (UHC) Day

The International Decision Support Initiative (iDSI) celebrated Universal Health Coverage (UHC) day on 12th December 2017 at the Center for Global Development (CGD) in Washington DC. The event was titled ‘Better Decisions, Better Health: Practical Experiences Supporting UHC from around the world”. P

Establishment of the Medical Technology Assessment Board (MTAB): Initiating Health Technology Assessment (HTA) in India

Since 2013, the HITAP International Unit (HIU) has been providing technical support to various developing countries such as Indonesia, Vietnam, Bhutan, and India by sharing the Thai experience in generating and using health technology assessment (HTA) to inform policy decisions. HITAP works in colla

What is the value of a Quality-Adjusted Life Year and How Much Is It ?

The value of a Quality-Adjusted Life Year (QALY) used to screen medicines for inclusion in the National List of Essential Medicines (NLEM) in 2013 was 160,000 baht per QALY. Any medicines that cost less than this amount is considered to be cost-effective. However, is this figure consistent with publ
10 / Page